Roivant Sciences

Roivant Sciences is dedicated to transforming patient health by accelerating the delivery of innovative medicines and advanced healthcare technologies. We achieve this mission by establishing Vants – a network of nimble, entrepreneurial biotech and healthcare technology companies. These entities are strategically designed to address critical unmet medical needs, particularly in disease areas where research and development investment has been disproportionately low compared to societal necessity.

Our Vants foster a culture of innovation, leveraging a unique approach to talent, incentive alignment, and technology deployment to drive progress. The diverse therapies in development across our family of companies target a wide range of conditions, including uterine fibroids, Parkinson’s disease, and rare pediatric conditions, alongside pioneering efforts in improving medicine development and commercialization processes. Discover more about our impact and opportunities to contribute to better health outcomes.